Coherus Oncology, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Redwood City, CA
CHRS chart
What traders are saying about $CHRS
Latest postsCoherus Oncology, Inc. news
- Coherus schedules November 9 results. Coherus Oncology stock gains 4.68 percent
ad-hoc-news.de ·
- Coherus Oncology to present at two major health...
Pluang ·
- Coherus to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- Coherus Oncology Inc expected to post a loss of 22 cents a share - Earnings Preview
TradingView ·
- Coherus Oncology Announces Third Quarter 2026 Financial Results Conference Call and Webcast Scheduled for November 9
Quiver Quantitative ·
- Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026
Yahoo Finance ·
- Coherus Oncology stock trades 61.45 percent below its 52-week high
ad-hoc-news.de ·
- Coherus Oncology, Inc. Estimates – NASDAQ:CHRS
TradingView ·
- Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026
Yahoo Finance ·
- Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets
Yahoo Finance ·
- Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
Yahoo Finance ·
- Coherus Oncology (CHRS) Q2 2026 Earnings Call Transcript
fool.com ·
Coherus Oncology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | $168.0M | $28.5M | -$237.9M | -$291.8M |
| Diluted EPS | $1.43 | $0.25 | $-2.53 | $-3.76 |
| Total assets (year end) | $258.3M | $448.5M | $629.6M | $480.8M |
| Cash and equivalents (year end) | $88.9M | $126.0M | $102.9M | $63.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Coherus Oncology, Inc.
- Ticker
- CHRS (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Redwood City, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1512762
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
Frequently asked questions
What exchange is Coherus Oncology, Inc. listed on?
Coherus Oncology, Inc. trades on the Nasdaq under the ticker symbol CHRS.
What industry is Coherus Oncology, Inc. in?
Coherus Oncology, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Coherus Oncology, Inc. headquartered?
Coherus Oncology, Inc.'s business address on file with the SEC is in Redwood City, CA.
When does Coherus Oncology, Inc.'s fiscal year end?
Coherus Oncology, Inc.'s fiscal year ends on December 31.
How much revenue did Coherus Oncology, Inc. report?
Coherus Oncology, Inc. reported $0 in revenue for calendar year 2018, according to its SEC filings.